Interfering with ITGB1-DT Expression Delays Cancer Progression and Promotes Cell Sensitivity of NSCLC to Cisplatin by Inhibiting the MAPK/ERK Pathway.
PubMed（2022）
Key words
ITGB1-DT,MAPK,NSCLC,overall survival,disease-specific survival,progression-free interval
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined